NE-CHMIMO

NE-CHMIMO

Legal status
Legal status	CA: Schedule II
Identifiers
IUPAC name [1-(cyclohexylmethyl)-1H-indol-3-yl](naphthalen-1-yl)methanone
CAS Number	1373876-11-9
Chemical and physical data
Formula	C26H25NO
Molar mass	367.49 g·mol^−1
3D model (Jmol)	Interactive image
SMILES O=C(c1cccc2ccccc12)c3cn(CC4CCCCC4)c5ccccc35
InChI InChI=1S/C26H25NO/c28-26(23-15-8-12-20-11-4-5-13-21(20)23)24-18-27(17-19-9-2-1-3-10-19)25-16-7-6-14-22(24)25/h4-8,11-16,18-19H,1-3,9-10,17H2 Key:HGJYPIZWMHHQKS-UHFFFAOYSA-N

NE-CHMIMO (CHM-018) is an indole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB₁ receptor and has been sold online as a designer drug.^[1][2] NE-CHMIMO is the 1-cyclohexylmethyl (instead of 1-pentyl) analogue of the first-generation synthetic cannabinoid JWH-018. The corresponding cyclohexylmethyl derivative of JWH-081 had also been reported several months earlier.^[3]

See also

• AB-CHMINACA
• ADB-CHMINACA
• APP-CHMINACA
• FUB-018
• MDMB-CHMICA
• MDMB-CHMINACA

References

1. Verena Angerer; Philippe Bisel; Bjoern Moosmann; Folker Westphal; Volker Auwärter (June 2016). "Separation and structural characterization of the new synthetic cannabinoid JWH-018 cyclohexyl methyl derivative "NE-CHMIMO" using flash chromatography, GC-MS, IR and NMR spectroscopy". Forensic Science International. doi:10.1016/j.forsciint.2016.05.031. PMID 27297324.
2. "NE-CHMIMO". New Synthetic Drugs Database.
3. Karen Blakey; Sue Boyd; Sarah Atkinson; Jenna Wolf; Pim M. Slottje; Katrina Goodchild; Jenny McGowan (March 2016). "Identification of the novel synthetic cannabimimetic 8-quinolinyl 4-methyl-3-(1-piperidinylsulfonyl)benzoate (QMPSB) and other designer drugs in herbal incense". Forensic Science International. 260: 40–53. doi:10.1016/j.forsciint.2015.12.001. PMID 26795397.